SANOFI-AVENTIS U S

Downmodulation of the expression of several molecules that control T-cell activation (ie, TCR/CD3, CD4, CD8, CD25, CD45,... View a full depiction of the mechanisms of acute rejection and how Thymoglobulin may help with prevention or treatment... Indication: Thymoglobulin® (anti-thymocyte globulin (rabbit)) is indicated for the prophylaxis and treatment of acute rejection in patients receiving a kidney transplant. Thymoglobulin is to be used in conjunction with concomitant immunosuppression.

Also known as: sanofi-aventis U.S. LLC